Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation - PubMed (original) (raw)
Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation
R Foster et al. Mol Cell Biol. 1996 Jun.
Abstract
We have identified a human Rho protein, RhoE, which has unusual structural and biochemical properties that suggest a novel mechanism of regulation. Within a region that is highly conserved among small GTPases, RhoE contains amino acid differences specifically at three positions that confer oncogenicity to Ras (12, 59, and 61). As predicted by these substitutions, which impair GTP hydrolysis in Ras, RhoE binds GTP but lacks intrinsic GTPase activity and is resistant to Rho-specific GTPase-activating proteins. Replacing all three positions in RhoE with conventional amino acids completely restores GTPase activity. In vivo, RhoE is found exclusively in the GTP-bound form, suggesting that unlike previously characterized small GTPases, RhoE may be normally maintained in an activated state. Thus, amino acid changes in Ras that are selected during tumorigenesis have evolved naturally in this Rho protein and have similar consequences for catalytic function. All previously described Rho family proteins are modified by geranylgeranylation, a lipid attachment required for proper membrane localization. In contrast, the carboxy-terminal sequence of RhoE predicts that, like Ras proteins, RhoE is normally farnesylated. Indeed, we have found that RhoE in farnesylated in vivo and that this modification is required for association with the plasma membrane and with an unidentified cellular structure that may play a role in adhesion. Thus, two unusual structural features of this novel Rho protein suggest a striking evolutionary divergence from the Rho family of GTPases.
Similar articles
- Crystal structure of the core domain of RhoE/Rnd3: a constitutively activated small G protein.
Garavini H, Riento K, Phelan JP, McAlister MS, Ridley AJ, Keep NH. Garavini H, et al. Biochemistry. 2002 May 21;41(20):6303-10. doi: 10.1021/bi025651h. Biochemistry. 2002. PMID: 12009891 - Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
Murphy GA, Solski PA, Jillian SA, Pérez de la Ossa P, D'Eustachio P, Der CJ, Rush MG. Murphy GA, et al. Oncogene. 1999 Jul 1;18(26):3831-45. doi: 10.1038/sj.onc.1202758. Oncogene. 1999. PMID: 10445846 - ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers.
Luo RZ, Fang X, Marquez R, Liu SY, Mills GB, Liao WS, Yu Y, Bast RC. Luo RZ, et al. Oncogene. 2003 May 15;22(19):2897-909. doi: 10.1038/sj.onc.1206380. Oncogene. 2003. PMID: 12771940 - Function and regulation of RhoE.
Riento K, Villalonga P, Garg R, Ridley A. Riento K, et al. Biochem Soc Trans. 2005 Aug;33(Pt 4):649-51. doi: 10.1042/BST0330649. Biochem Soc Trans. 2005. PMID: 16042565 Review. - Biochemical analyses of the Wrch atypical Rho family GTPases.
Shutes A, Berzat AC, Chenette EJ, Cox AD, Der CJ. Shutes A, et al. Methods Enzymol. 2006;406:11-26. doi: 10.1016/S0076-6879(06)06002-2. Methods Enzymol. 2006. PMID: 16472646 Review.
Cited by
- Rnd3 Is a Crucial Mediator of the Invasive Phenotype of Glioblastoma Cells Downstream of Receptor Tyrosine Kinase Signalling.
Almarán B, Ramis G, Fernández de Mattos S, Villalonga P. Almarán B, et al. Cells. 2022 Nov 22;11(23):3716. doi: 10.3390/cells11233716. Cells. 2022. PMID: 36496976 Free PMC article. - The cellular biochemistry of cholesterol and statins: insights into the pathophysiology and therapy of Alzheimer's disease.
Wolozin B, Brown J 3rd, Theisler C, Silberman S. Wolozin B, et al. CNS Drug Rev. 2004 Summer;10(2):127-46. doi: 10.1111/j.1527-3458.2004.tb00009.x. CNS Drug Rev. 2004. PMID: 15179443 Free PMC article. Review. - A role of Rnd1 GTPase in dendritic spine formation in hippocampal neurons.
Ishikawa Y, Katoh H, Negishi M. Ishikawa Y, et al. J Neurosci. 2003 Dec 3;23(35):11065-72. doi: 10.1523/JNEUROSCI.23-35-11065.2003. J Neurosci. 2003. PMID: 14657163 Free PMC article. - Small GTPase RhoE/Rnd3 is a critical regulator of Notch1 signaling.
Zhu Z, Todorova K, Lee KK, Wang J, Kwon E, Kehayov I, Kim HG, Kolev V, Dotto GP, Lee SW, Mandinova A. Zhu Z, et al. Cancer Res. 2014 Apr 1;74(7):2082-93. doi: 10.1158/0008-5472.CAN-12-0452. Epub 2014 Feb 13. Cancer Res. 2014. PMID: 24525741 Free PMC article. - Rho GTPases control specific cytoskeleton-dependent functions of hematopoietic stem cells.
Nayak RC, Chang KH, Vaitinadin NS, Cancelas JA. Nayak RC, et al. Immunol Rev. 2013 Nov;256(1):255-68. doi: 10.1111/imr.12119. Immunol Rev. 2013. PMID: 24117826 Free PMC article. Review.
References
- Science. 1988 Dec 23;242(4886):1697-700 - PubMed
- Oncogene. 1995 Jul 6;11(1):39-48 - PubMed
- Cancer Res. 1989 Sep 1;49(17):4682-9 - PubMed
- Nature. 1989 Aug 31;340(6236):692-6 - PubMed
- EMBO J. 1990 Aug;9(8):2351-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials